That is exactly the problem in many cases and why the "cure" is so important. Even a better delivery system might help. ----- Original Message ----- From: "m power" <[log in to unmask]> To: <[log in to unmask]> Sent: Monday, January 16, 2006 9:42 PM Subject: Re: mirapex and requip/P.S. > two scary things i found in quest for information > about mirapex and l-dopa > > 1) quote from a datamonitor.com brochure advertising > their market research studies, including Parkinson's > > "Commercial Insight: Parkinson's Disease - Increased > focus on Earlier Treatment and Managing Levodopa > Complications Will Drive Market Growth" > > Note: not "Finding a better drug than levodopa," but > "We are going to keep selling you levodopa and then > sell you MORE drugs to fix the problems levodopa > causes" - excellent! and i wonder if "earlier > treatment' includes neuroprotection, or just making us > paying customers earlier... > > 2) quote from a website called yourlawyer.com that > will evaluate your mirapex experience for lawsuit > potential > (http://www.yourlawyer.com/topics/overview/mirapex/): > > "Levodopa, a popular Parkinson's drug which is not a > dopamine agonist was not linked to any compulsive > behaviors....Although, Levodopa is not linked > to gambling, an estimated 30 percent of Parkinson's > patients still take dopamine agonists like Mirapex. " > > my fear is that people who might very well benefit > from this drug will either decide not to try it or > perhaps not even be given the opportunity by their > doctors. > > mackenzie > > __________________________________________________ > Do You Yahoo!? > Tired of spam? Yahoo! Mail has the best spam protection around > http://mail.yahoo.com > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: > mailto:[log in to unmask] > In the body of the message put: signoff parkinsn > > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn